285 related articles for article (PubMed ID: 29295756)
21. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.
Sun S; Gao F; Mao Q; Shao J; Jiang L; Liu D; Wang Y; Yao X; Wu X; Sun B; Zhao D; Ma Y; Lu J; Kong W; Jiang C; Liang Z
Hum Vaccin Immunother; 2015; 11(10):2406-13. PubMed ID: 26036916
[TBL] [Abstract][Full Text] [Related]
23. Single B cells reveal the antibody responses of rhesus macaques immunized with an inactivated enterovirus D68 vaccine.
Zheng H; Yang Z; Li B; Li H; Guo L; Song J; Hou D; Li N; Yang J; Wu Q; Sun M; Liu L
Arch Virol; 2020 Aug; 165(8):1777-1789. PubMed ID: 32462286
[TBL] [Abstract][Full Text] [Related]
24. High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice.
Zhang C; Ku Z; Liu Q; Wang X; Chen T; Ye X; Li D; Jin X; Huang Z
Vaccine; 2015 May; 33(20):2335-41. PubMed ID: 25820068
[TBL] [Abstract][Full Text] [Related]
25. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
[TBL] [Abstract][Full Text] [Related]
26. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
27. Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design.
Lin SY; Yeh CT; Li WH; Yu CP; Lin WC; Yang JY; Wu HL; Hu YC
Biotechnol Bioeng; 2015 Oct; 112(10):2005-15. PubMed ID: 25997678
[TBL] [Abstract][Full Text] [Related]
28. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
29. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.
Li HY; Han JF; Qin CF; Chen R
Vaccine; 2013 Jul; 31(32):3281-7. PubMed ID: 23726823
[TBL] [Abstract][Full Text] [Related]
30. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
[TBL] [Abstract][Full Text] [Related]
31. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
32. Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice.
Zhou Y; Shen C; Zhang C; Zhang W; Wang L; Lan K; Liu Q; Huang Z
Antiviral Res; 2016 Aug; 132():165-9. PubMed ID: 27315772
[TBL] [Abstract][Full Text] [Related]
33. Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections.
Zhang C; Xu C; Dai W; Wang Y; Liu Z; Zhang X; Wang X; Wang H; Gong S; Cong Y; Huang Z
Nat Commun; 2021 May; 12(1):2904. PubMed ID: 34006855
[TBL] [Abstract][Full Text] [Related]
34. Nasal Infection of Enterovirus D68 Leading to Lower Respiratory Tract Pathogenesis in Ferrets (Mustela putorius furo).
Zheng HW; Sun M; Guo L; Wang JJ; Song J; Li JQ; Li HZ; Ning RT; Yang ZN; Fan HT; He ZL; Liu LD
Viruses; 2017 May; 9(5):. PubMed ID: 28489053
[TBL] [Abstract][Full Text] [Related]
35. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice.
Zhang C; Liu Q; Ku Z; Hu Y; Ye X; Zhang Y; Huang Z
Antiviral Res; 2016 May; 129():47-51. PubMed ID: 26902108
[TBL] [Abstract][Full Text] [Related]
36. Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease.
Vogt MR; Fu J; Kose N; Williamson LE; Bombardi R; Setliff I; Georgiev IS; Klose T; Rossmann MG; Bochkov YA; Gern JE; Kuhn RJ; Crowe JE
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32620559
[TBL] [Abstract][Full Text] [Related]
37. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
38. Enterovirus D68 serosurvey: evidence for endemic circulation in the Netherlands, 2006 to 2016.
Karelehto E; Koen G; Benschop K; van der Klis F; Pajkrt D; Wolthers K
Euro Surveill; 2019 Aug; 24(35):. PubMed ID: 31481149
[TBL] [Abstract][Full Text] [Related]
39. A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge.
Lin YL; Cheng PY; Chin CL; Chuang KT; Lin JY; Chang N; Pan CK; Lin CS; Pan SC; Chiang BL
J Biomed Sci; 2023 Dec; 30(1):96. PubMed ID: 38110940
[TBL] [Abstract][Full Text] [Related]
40. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
